NLM Logo

ADA protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
ADA protocol
Unique ID
C430505
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C430505
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Asparaginase
Cytarabine
Daunorubicin
Frequency
2
Note
chemotherapy protocol consisting of above cpds; used in treatment of acute lymphoblastic leukemia
Source
Leukemia 2001 Jun;15(6):898-902
Date of Entry
2001/07/11
ADA protocol Preferred
page delivered in 0.005s